急诊科抗菌药物延迟与脓毒症患儿死亡风险
这项回顾性队列研究纳入美国51家儿童医院2017年1月1日至2021年12月31日、年龄29天至不足18岁、到急诊1小时内识别脓毒症的19515例患儿,用分段回归确定脓毒症归因3天死亡率拐点为330分钟。抗菌药物在330分钟内使用者19164例,3天脓毒症归因死亡率0.5%(93例)、30天死亡率0.9%(163例);330分钟及以上使用者351例,3天死亡率1.2%(4例)、30天死亡率2.0%(7例),校正后3天死亡OR 3.44(95%CI 1.20-9.93,P=0.02)、30天死亡OR 3.63(95%CI 1.59-8.30,P=0.002)。作者认为需进一步研究是否存在休克或菌血症等亚群可从更早用药获益。
要点
- 脓毒症患儿自急诊到院至抗菌药物给药≥330分钟者,3天脓毒症归因死亡校正OR 3.44(95%CI 1.20-9.93,P=0.02)。
- 同一330分钟阈值组30天脓毒症归因死亡校正OR 3.63(95%CI 1.59-8.30,P=0.002)。
- 330分钟内用药者19164例,3天脓毒症归因死亡率0.5%(93例)、30天死亡率0.9%(163例)。
- 330分钟及以上用药者351例,3天脓毒症归因死亡率1.2%(4例)、30天死亡率2.0%(7例)。
- 全体患儿到院至抗菌药物给药中位时间69分钟(IQR 47-116分钟),年龄中位6岁(IQR 2-12岁)。
适用人群与场景
- 美国51家儿童医院、改善儿科脓毒症结局协作组数据,年龄29天至不足18岁、到急诊1小时内识别为脓毒症的患儿,2017年1月1日至2021年12月31日。
诊断标准与关键阈值
- 分段回归估计的脓毒症归因3天死亡率拐点为自急诊到院至抗菌药物给药330分钟。
研究设计与关键结果
- 回顾性队列研究,纳入19515例,年龄中位6岁(IQR 2-12岁),到院至抗菌药物给药中位69分钟(IQR 47-116分钟)。
- 330分钟内用药19164例,3天脓毒症归因死亡率0.5%(93例),30天死亡率0.9%(163例)。
- 330分钟及以上用药351例,3天脓毒症归因死亡率1.2%(4例),30天死亡率2.0%(7例)。
- 与330分钟内用药相比,330分钟及以上用药者校正后3天死亡OR 3.44(95%CI 1.20-9.93,P=0.02),30天死亡OR 3.63(95%CI 1.59-8.30,P=0.002)。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:作者指出需进一步研究是否存在休克或菌血症等亚群可从更早使用抗菌药物中获益。
对床旁实践的改变
- 作者认为,为平衡资源分配与充分诊断评估的时间,需进一步研究是否存在休克或菌血症等亚群可从更早用药获益。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Pediatric consensus guidelines recommend antibiotic administration within 1 hour for septic shock and within 3 hours for sepsis without shock. Limited studies exist identifying a specific time past which delays in antibiotic administration are associated with worse outcomes.
OBJECTIVE: To determine a time point for antibiotic administration that is associated with increased risk of mortality among pediatric patients with sepsis.
DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study used data from 51 US children's hospitals in the Improving Pediatric Sepsis Outcomes collaborative. Participants included patients aged 29 days to less than 18 years with sepsis recognized within 1 hour of emergency department arrival, from January 1, 2017, through December 31, 2021. Piecewise regression was used to identify the inflection point for sepsis-attributable 3-day mortality, and logistic regression was used to evaluate odds of sepsis-attributable mortality after adjustment for potential confounders. Data analysis was performed from March 2022 to February 2024.
EXPOSURE: The number of minutes from emergency department arrival to antibiotic administration.
MAIN OUTCOMES AND MEASURES: The primary outcome was sepsis-attributable 3-day mortality. Sepsis-attributable 30-day mortality was a secondary outcome.
RESULTS: A total of 19 515 cases (median [IQR] age, 6 [2-12] years) were included. The median (IQR) time to antibiotic administration was 69 (47-116) minutes. The estimated time to antibiotic administration at which 3-day sepsis-attributable mortality increased was 330 minutes. Patients who received an antibiotic in less than 330 minutes (19 164 patients) had sepsis-attributable 3-day mortality of 0.5% (93 patients) and 30-day mortality of 0.9% (163 patients). Patients who received antibiotics at 330 minutes or later (351 patients) had 3-day sepsis-attributable mortality of 1.2% (4 patients), 30-day mortality of 2.0% (7 patients), and increased adjusted odds of mortality at both 3 days (odds ratio, 3.44; 95% CI, 1.20-9.93; P = .02) and 30 days (odds ratio, 3.63; 95% CI, 1.59-8.30; P = .002) compared with those who received antibiotics within 330 minutes.
CONCLUSIONS AND RELEVANCE: In this cohort of pediatric patients with sepsis, 3-day and 30-day sepsis-attributable mortality increased with delays in antibiotic administration 330 minutes or longer from emergency department arrival. These findings are consistent with the literature demonstrating increased pediatric sepsis mortality associated with antibiotic administration delay. To guide the balance of appropriate resource allocation with time for adequate diagnostic evaluation, further research is needed into whether there are subpopulations, such as those with shock or bacteremia, that may benefit from earlier antibiotics.
参考来源
- Lane RD, Richardson T, Scott HF, et al. Delays to Antibiotics in the Emergency Department and Risk of Mortality in Children With Sepsis. JAMA Netw Open. 2024. PMID: 38837160. doi:10.1001/jamanetworkopen.2024.13955
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。